Losartan improves effectiveness of nanotherapeutics against cancer

Links shared publicly online about this topic.

534
total visits

Losartan improves effectiveness of nanotherapeutics against cancer

Low doses of an inexpensive, FDA-approved hypertension medication may improve the results of nanotherapeutic approaches to cancer treatment. In a report in the early edition of Proceedings of the National Academy of Sciences, Massachusetts General Hospital (MGH) investigators describe experiments showing that the generic drug losartan, by modifying the network of collagen fibers that characterizes most solid tumors, improved the effectiveness of two nanotherapeutics against several types of canc

View full resource at news-medical.net

Tags: Heart Disease, High Blood Pressure, High Blood Pressure Medication, Genetic, Cancer, Cozaar, Hyzaar, News